Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01639144 · ClinicalTrials.gov registry record · NA
Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing
A NA study of Elective Foot and Ankle Surgery., sponsored by Gary M. Kiebzak, Ph.D..
- Completed
- Registry status
- NA
- Development phase
- 515
- Enrollment target
- 1
- Study location
NCT01639144: Completed NA study of Elective Foot and Ankle Surgery., sponsored by Gary M. Kiebzak, Ph.D..
NCT01639144 is a NA study of Elective Foot and Ankle Surgery. that has completed, run by Gary M. Kiebzak, Ph.D.. The registered enrollment target is 515 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01639144, a NA study of Elective Foot and Ankle Surgery., has completed, sponsored by Gary M. Kiebzak, Ph.D..
- COMPLETED
- Registry status
- NA
- Development phase
- 515 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.
Primary Outcome
Postoperative deep incisional surgical site infection and delayed wound healing (lack of primary healing of skin edges typically with wound secretion).
Conditions Studied
Interventions
- BIOLOGICAL PRP and PPP
Study Locations (1)
Florida
- UHZ Sports Medicine Institute - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT01639144 record still lists
NCT01639144 is an interventional study that assigns participants to a tested intervention. The registered 515 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Elective Foot and Ankle Surgery. appearing as the primary indexed condition, and to 1 intervention - of which PRP and PPP is the first listed.
NCT01639144 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01639144 about?
NCT01639144 is a clinical study titled "Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing". The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.
What is the current status of trial NCT01639144?
This trial is currently completed. It is a NA study. The enrollment target is 515 participants. The study started on 2012-07. Estimated completion is 2015-03.
What conditions does trial NCT01639144 study?
This clinical trial studies the following conditions: Elective Foot and Ankle Surgery..
What interventions are being tested in trial NCT01639144?
The interventions under investigation include: PRP and PPP (BIOLOGICAL).
Who is sponsoring clinical trial NCT01639144?
This trial is sponsored by Gary M. Kiebzak, Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01639144 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01639144's enrollment target sits among peer trials
515 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia